Publication | Closed Access

Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts

Intratumoral SteroidogenesisUrologyOncologyMedicinePharmacotherapyOral Simvastatin AdministrationCastration-resistant ProgressionCancer TreatmentProstatic DiseasePharmacologyTumor Biology